Therapeutics

151 trials 76 recruiting

Filter these 151 trials by phase, country and sponsor.

Open in Search →

A clinical trial applying Regulatory T cells in kidney transplant recipients to investigate the safety and tolerability as an adjunctive the… Recruiting

2024-514398-23-00 Solid organ transplantation (Kidney) 9 2024-06-10
A Phase III Randomized Controlled Multicentre Trial of Percutaneous Hepatic Perfusion in Combination with Ipilimumab and Nivolumab Compared … Recruiting

2023-508156-20-00 Uveal Melanoma Liver Metastases 5 2024-06-10
Avoiding Risks of Thrombosis and bleeding in Surgery (ARTS) trial Recruiting

2023-508147-43-00 Venous thromboembolism (in surgical patients) 6 2024-05-31
Renal Outcomes in the early use of vasopressin in the treatment of septic shock Recruiting

2023-509071-16-00 Septic shock 6 2024-05-22
EFFECT OF THE USE OF DAPAGLIFLOZIN IN DIURESIS, NATRIURIESIS AND IN ULTRAFILTRATION AND PERITONEAL ELIMINATION OF SODIUM, IN PATIENTS WITH R… Recruiting

2023-505571-78-00 REFRACTORY HEART FAILURE 6 2024-05-16
DUMELEP trial - Durvalumab (MEDI4736)/Tremelimumab in neoadjuvant and adjuvant setting in patients with HCC treated by percutaneous ablation… Recruiting

2024-515768-30-01 Hepatocellular carcinoma 4 2024-03-28
Pan-tumor neoadjuvant basket study of immune check-point inhibition and novel IO combinations (NEOASIS) Recruiting

2023-505756-21-00 dMMR tumors consisting of but not limited to; Colorecta 4 2024-01-26
FIRE Stones : Impact of Furosemide on the residual fragment rate after flexible ureteroscopy for destruction of kidney stones with laser : a… Recruiting

2022-502890-40-00 Destruction of kidney stones 5 2024-01-04
Patient Walking Rehabilitation Program with osteoarthritis of the hip or knee helped by a one-off anti-inflammatory treatment (pilot cohort … Recruiting

2022-502018-10-00 Idiopathic osteoarthritis of the hip or knee 6 2023-11-07
Phase II, multicenter, randomized, open-label study of premenopausal women with luminal breast cancer investigating the effect of elacestran… Recruiting

2023-503373-37-01 Premenopausal women with early luminal breast cancer 4 2023-09-11
Does peri-operative treatment with Tranexamic Acid reduce the early relapse rate for patients with melanoma; a randomised controlled trial Recruiting

2022-502633-26-00 Melanoma Surgery 5 2023-08-25
Maintenance Pembrolizumab at Usual or Low doSE in non-squamous lung cancer: a non-inferiority study Recruiting

2023-503481-23-00 Maintenance treatment in metastatic non-squamous lung c 5 2023-03-20
Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into platinum/pemetrexed-based first-line treatment for epithelioid m… Recruiting

2024-515293-27-00 Malignant pleural mesothelioma, epithelioid subtype (st 4 2023-02-24
Efficacy comparison of two doses of vitamin D3 in critically ill patients undergoing continuous renal replacement therapy - NephroD Recruiting

2024-510834-42-00 Vitamin D3 deficiency 6 2022-12-19
Phase I study of 225Ac-PSMA I&T in prostate cancer Recruiting

2024-513729-22-01 metastatic prostate cancer 2 2022-02-01
A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally adva… Recruiting

2024-513820-40-00 Metastatic or locally advanced leiomyosarcoma 4 2021-10-29
LANDI-POAF study Recruiting

2024-518950-17-00 Beta-blocker intake 5 2021-10-18
Intra-arterial hepatic (IAH) infusion of radiolabelled somatostatin analogs in GEP-NET patients with dominant liver metastases Recruiting

2024-514785-39-00 Gastroenteropancreatic neuroendocrine tumours (GEP-NETs 4 2021-09-24
A multicenter, prospective, randomized, placebo-controlled, double-blind, multi-arm, multi-stage clinical trial of Ivabradine for heart Rate… Recruiting

2024-515019-22-00 Septic shock 5 2021-02-26
GROINSS-V III Recruiting

2023-508722-99-00 Vulvar cancer 4 2020-11-19
Wilms’ tumor (WT1) antigen-targeted dendritic cell vaccination to prevent relapse in adult patients with acute myeloid leukemia: a multicent… Ended

2024-515292-35-00 Acute Myeloid Leukemia 4 2026-01-09
REDUCE PMR: Rituximab Effect on Decreasing glUcoCorticoid Exposition in relapsing PolyMyalgia Rheumatica Ended

2024-513545-37-00 Polymyalgia rheumatica 6 2023-02-09
LEGACY Ended

2023-504360-42-00 Non-ST-segment elevation acute coronary syndrome 6 2022-05-13
Induction chemotherapy for locally advanced rectal cancer. Ended

2023-509758-74-00 Locally advanced rectal cancer 4 2021-07-21